Login
Related Links
Advertise on this site?
Advertising opportunities on Gene Therapy Net include standard size banners as well as text ads. Click here for more information about advertising.
You can also make a donation by PayPal and support the Gene Therapy Net website.
Companies - V
VBL Therapeutics VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biotechnology company focused on the discovery, development and commercialization of first in class treatments for cancer. VBL’s clinical pipeline is based on two distinct, proprietary platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. To date, VBL has developed two programs based on these platforms – an oncology program and an anti-inflammatory program. VBL is based in Tel Aviv, Israel. |
|
Vector Gene Technology Company, Ltd. VGTC is a leader in recombinant adeno-associated virus (rAAV) large-scale manufacturing. Its novel AAV package and purification systems make the producing of AAV to be one of the most cost-effective AAV producing systems. |
|
Vical Incorporated Biotechnology company developing biopharmaceutical products based on DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases, like infections diseases and cancer. |
|
VirRx, Inc. Biotechnology company with a primary interest in cancer gene therapy. Its broad mission is to develop genetically modified "smart bomb" adenoviruses for use in treating human cancers. |
|
VIVEbioTECH S.L. A Spanish biotech company which specialises in gene transfer technologies, and in particular those related to the production of viral vectors under GMP conditions, and their gene therapy applications. |
|
Information Companies
Overview of biotechnology companies involved in gene therapy and/or cell therapy, as well as contract research organizations (CRO) and medical supply companies.
The provided information about the companies is just a summary of the information giving on their websites and is therefore not always complete, correct and/or exhaustive. Please visit the companies websites for a complete picture of the company.
Your company not listed? Click here to submit.
Like to work for a company? Find here the perfect job in gene therapy.
Gene Therapy News
- Gene therapy improves or reverses age-related disease in mice - McKnight's Long-Term Care News
Sat, 20 Apr 2024 02:53:0 GMT - Ferring takes steps to ensure long term supply of gene therapy - The Pharma Letter
Sat, 20 Apr 2024 01:41:4 GMT - Cell and gene therapy approach shows promise for EB children - Epidermolysis Bullosa News
Fri, 19 Apr 2024 20:49:0 GMT - Q&A: Cell and gene therapy value assessments need a rework to allow access - Pharmaceutical Technology
Fri, 19 Apr 2024 18:05:1 GMT - Do P&T Committees Need Help With Cell and Gene Therapy? | AMCP 2024 - Managed Healthcare Executive
Fri, 19 Apr 2024 16:17:3 GMT - AskBio's AB-1002 gene therapy receives FDA fast-track status - Pharmaceutical Technology
Fri, 19 Apr 2024 12:23:2 GMT - New gene therapy platform is helping transform lives - Spectrum News 1
Fri, 19 Apr 2024 12:15:0 GMT - Long Island boy with rare blood disorder undergoes gene therapy - PIX11 New York News
Fri, 19 Apr 2024 01:39:1 GMT - New gene therapy eliminates need for bone marrow transplant. Here's how it works. - CBS News
Fri, 19 Apr 2024 00:35:0 GMT - Long Island boy undergoes groundbreaking gene therapy - CBS New York - CBS News
Fri, 19 Apr 2024 00:35:0 GMT - Boy with rare blood disorder receives new life-changing gene therapy treatment - FOX 5 New York
Thu, 18 Apr 2024 23:52:2 GMT - Medical breakthrough: 8-year-old boy first in New York to receive FDA-approved gene therapy for rare inherited blood disorder - WABC-TV
Thu, 18 Apr 2024 22:56:0 GMT - Hospital gives first dose of gene therapy for DMD in WV - WDTV
Thu, 18 Apr 2024 21:47:0 GMT - Hospital gives first dose of gene therapy for Duchenne Muscular Dystrophy in WV - WDTV
Thu, 18 Apr 2024 21:23:0 GMT - Hospital gives first dose of gene therapy for Duchenne Muscular Dystrophy in WV - WVVA
Thu, 18 Apr 2024 21:23:0 GMT